Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Efficient patient monitoring on the medical-surgical wards is crucial to prevent significant in-hospital adverse events. Standard episodic inpatient assessment of vital signs can potentially miss changes in health status and delay recognition of elevated risk. To reduce the likelihood of this delayed recognition of risk, we developed a wearable-based deep learning model, using only 9 inputs, to identify the onset of deterioration earlier than traditional early warning systems. We showed this model could generalize to produce clinical alerts ahead of a broad class of significant adverse clinical outcomes, including rapid response team (RRT) interventions, unplanned intensive care unit (ICU) transfers, intubations, cardiac arrests, and in-hospital deaths. Using data from 888 adult non-ICU inpatient visits in four hospitals in New York and employing two different clinical grade wearable biosensors (4-8% data missingness, excluding SpO2), as part of a quality initiative, we trained a recurrent neural network (RNN) to predict both MEWS alerts and adverse clinical outcomes. Using multiple stages of validation, we showed in our retrospective, time-sequence duration optimized, prospective validation the RNN model was able to predict both periods of elevated MEWS scores (ROC AUC 0.89 +/- 0.3, PR AUC 0.58 +/- 0.14) and adverse clinical outcomes (accuracy: 81.8% on 11 events) up to an average of 17 hours in advance. Our results show that our wearable based RNN alert system outperforms traditional episodic clinical support tools in detecting early onset of inpatient deterioration; enabling timely interventions that can improve outcomes and reduce hospital costs for patients in early stages of deterioration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140530PMC
http://dx.doi.org/10.1101/2025.05.20.25327940DOI Listing

Publication Analysis

Top Keywords

adverse clinical
12
clinical outcomes
12
early warning
8
warning systems
8
alert system
8
clinical
7
episodic early
4
systems continuous
4
continuous clinical
4
clinical alert
4

Similar Publications

Background: Lower extremity arterial disease is a prevalent vascular condition leading to ischemic symptoms and increased risk of cardiovascular events. Drug-eluting stents have improved outcomes by reducing restenosis, with sirolimus emerging as a promising alternative to paclitaxel due to its safer profile. This study evaluates the efficacy and safety of novel polymer-free Amphilimus formulation (Sirolimus + fatty acid) eluting self-expanding stent in the treatment of femoropopliteal disease in a real-world population.

View Article and Find Full Text PDF

Importance: Patients with inflammatory rheumatic diseases (IRDs) frequently experience psychological distress; however, access to psychological support remains limited.

Objective: To investigate the effectiveness of a digital psychological intervention for individuals with IRDs.

Design, Setting, And Participants: Participants aged 18 years or older were recruited across Germany between February 22 and June 4, 2024, if they had been diagnosed with rheumatoid arthritis, psoriatic arthritis, or systemic lupus erythematosus and reported psychological distress and reduced quality of life.

View Article and Find Full Text PDF

Importance: Exposure to inflammation from chorioamnionitis places the fetus at higher risk of premature birth and may increase the risk of neurodevelopmental impairments, though the evidence for the latter is mixed.

Objective: To evaluate whether moderate to severe histologic chorioamnionitis (HCA) is directly associated with adverse motor performance, independent of the indirect mediating effects of premature birth.

Design, Setting, And Participants: This prospective, population-based cohort study recruited participants between September 16, 2016, and November 19, 2019, from referral and nonreferral neonatal intensive care units of 5 southwestern Ohio hospitals.

View Article and Find Full Text PDF

Background: Migraine care is often suboptimal owing to undertreatment, variation in clinical outcomes and administration methods among existing treatments, and between- and within-individual heterogeneity in the clinical course of migraine. In response to these challenges, preference studies have been increasingly conducted to inform treatment decision-making and development. However, gaps remain in understanding how treatment preferences have been assessed across different migraine studies.

View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach in gynecologic cancers, particularly ovarian and cervical malignancies. Agents such as mirvetuximab soravtansine, and tisotumab vedotin, targeting folate receptor alpha and tissue factor, respectively, reported clinical efficacy in patients with limited options. However, their use is associated with ocular toxicities, including keratopathy, blurred vision, and dry eye, which may impact adherence and quality of life.

View Article and Find Full Text PDF